- Home
- ALXO vs VHC Comparison
ALXO vs VHC Comparison
Compare ALXO & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- VHC
- Stock Information
- Founded
- ALXO 2015
- VHC 2005
- Country
- ALXO United States
- VHC United States
- Employees
- ALXO N/A
- VHC N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- VHC Multi-Sector Companies
- Sector
- ALXO Health Care
- VHC Miscellaneous
- Exchange
- ALXO Nasdaq
- VHC Nasdaq
- Market Cap
- ALXO 79.7M
- VHC 70.7M
- IPO Year
- ALXO 2020
- VHC 1999
- Fundamental
- Price
- ALXO $1.47
- VHC $20.79
- Analyst Decision
- ALXO Strong Buy
- VHC
- Analyst Count
- ALXO 6
- VHC 0
- Target Price
- ALXO $3.30
- VHC N/A
- AVG Volume (30 Days)
- ALXO 356.5K
- VHC 20.0K
- Earning Date
- ALXO 11-07-2025
- VHC 11-14-2025
- Dividend Yield
- ALXO N/A
- VHC N/A
- EPS Growth
- ALXO N/A
- VHC N/A
- EPS
- ALXO N/A
- VHC N/A
- Revenue
- ALXO N/A
- VHC $106,000.00
- Revenue This Year
- ALXO N/A
- VHC N/A
- Revenue Next Year
- ALXO N/A
- VHC N/A
- P/E Ratio
- ALXO N/A
- VHC N/A
- Revenue Growth
- ALXO N/A
- VHC 2020.00
- 52 Week Low
- ALXO $0.40
- VHC $3.68
- 52 Week High
- ALXO $2.27
- VHC $29.00
- Technical
- Relative Strength Index (RSI)
- ALXO 49.39
- VHC 52.36
- Support Level
- ALXO $1.29
- VHC $21.05
- Resistance Level
- ALXO $1.56
- VHC $25.83
- Average True Range (ATR)
- ALXO 0.18
- VHC 1.87
- MACD
- ALXO 0.01
- VHC -0.39
- Stochastic Oscillator
- ALXO 65.90
- VHC 41.14
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.